Меню
Идёт набор NCT07389720

Characterization of (A)Typical Sensorimotor Pathways in Individuals With Autism

Без фазы С лечением Autism Spectrum Disorder

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: clinical assessment, Neuropsychological examination, Neurophysiological evaluation, Genetic evaluation.
Кому может быть актуально
Состояния в реестре: Autism Spectrum Disorder. Базовые параметры: от 1 год · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Италия
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →

Обзор

The goal of this interventional study is to understand whether sensorimotor skills could represent an endophenotype for autism, i.e. a specific class of biomarkers that bridges the gap between biological components of a condition and the behavioral/clinical dimensions. Motor and sensory differences are often observed in people with autism and may appear early in development or be shared among family members. The study will address three main questions: * What are the developmental effects of early differences in motor and sensory skills? * Are motor and sensory abilities influenced by family relationships? * Can studying motor and sensory differences in autism help researchers better understand the biological mechanisms underlying the condition? This study is structured in three topic-oriented work packages (WPs): WP1, a longitudinal assessment of sensorimotor skills as early predictors of later social characteristics in a mixed sample of infant siblings of autistic children (at elevated likelihood of autism) or with typical familial likelihood (no first-degree relatives with autism) (Q1); WP2, a cross-sectional investigation of sensorimotor abilities in autistic children and their parents as compared with typically developing children and their parents (Q2); and WP3, a dense-phenotyping approach to establish, within individuals, associations between traits across behavioral, neural, and molecular levels.

Вмешательства

  • Диагностический тест clinical assessment
    Clinical evaluation of participants by means of Autism Diagnostic Observation Schedule, Social Responsiveness Scale
  • Диагностический тест Neuropsychological examination
    The participants' motor skills are measured using the Movement Assessment Battery for Children 3 (MABC3), the Developmental Coordination Disorder Questionnaire (DCDQ) or the Adult Developmental Coordination Disorder/Dyspraxia Checklist (ADC), and the kinematic analysis of upper-limb movements during two experimental tasks: (a) a reaching-and-inserting task involving a ball (ball task), and (b) a task requiring grasping a moving ball (ball-rolling task).
  • Диагностический тест Neurophysiological evaluation
    Magnetic Resonance Imaging (structural MRI and spectroscopy)
  • Диагностический тест Genetic evaluation
    Either blood or saliva will be obtained for participants for DNA collection. DNA will be extracted in the Molecular Biology Laboratory at the Scientific Institute IRCCS Medea. Captured exome libraries will be sequenced using the Illumina NextSeq 500 in 100 bp paired end reads. Postsequencing reads will be aligned using BWA Enrichment application on BaseSpace. Variant Call Format file will be then marked using wANNOVAR (Wang Genomics Lab). The analysis will be focused on non-synonymous variants e

Первичные конечные точки

  • Movement Assessment Battery for Children 3 (MABC3) [Срок оценки: immediately after the intervention]
  • Developmental Coordination Disorder Questionnaire (DCDQ) [Срок оценки: immediately after the intervention]
  • Adult Developmental Coordination Disorder/Dyspraxia Checklist (ADC) [Срок оценки: immediately after the intervention]
  • kinematic analysis of two motor tasks [Срок оценки: immediately after the intervention]
Вторичные конечные точки (3)
  • Magnetic Resonance (MRI) [Срок оценки: immediately after the intervention]
  • Magnetic Resonance Spectroscopy [Срок оценки: immediately after the intervention]
  • Exome sequencing [Срок оценки: immediately after the intervention]

Критерии участия

Критерии включения

  • children aged 2 to 12 years (both autistic and typically developing)
  • Clinical diagnosis of Autism Spectrum Disorder based on clinical judgment according to DSM-5 criteria (for the autism group).
  • being parents of the enrolled children (both autistic and typically developing)
  • infants younger than 24 months of age with a first-degree family member with a clinical diagnosis of Autism Spectrum Disorder.

Критерии исключения

  • Presence of medical and/or neurological conditions of clinical significance, including epilepsy.
  • Presence of dysmorphic syndromes or known genetic syndromes.
  • Current use of medications and/or psychotropic drugs.

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Да

Дизайн исследования

Распределение
Не применимо
Модель
Одна группа
Маскирование
Открытое
Основная цель
Диагностика

Центры проведения

Италия · 1 центр
  • IRCCS E. Medea — Bosisio Parini

Идентификаторы

NCT: NCT07389720 · 95/24 (ex 1105)

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗